ImmPheron, InNexus Corp., Cusil Venture Corp. deal

InNexus will reverse merge with CUS, under which 7.9 million shares of CUS will be distributed to InNexus shareholders. The merged company will be named InNexus Biotechnology Inc. Also, InNexus will ...